Ser-Leu-Ile-Gly-Lys-Val-NH2,
seryl-leucyl-isoleucyl-glycyl-lysyl-valinamide,
SLIGKV-NH2,
SLIGKV-NH2,
190383-13-2,
PAR2 activating peptide,
PAR2-AP,
PAR-2 (1-6) Human,
Ser-Leu-Ile-Gly-Lys-Val-amide,
H-Ser-Leu-Ile-Gly-Lys-Val-NH2,
Protease-Activated Receptor-2, amide,
CHEMBL4084322,
Ser-Leu-Ile-Gly-Lys-Val-NH2,
BDBM85084,
DTXSID70440595,
PAR-2 (1-6) amide (human),
HY-P0283,
MFCD02259590,
ZINC89455997,
AKOS024457380,
LS-192923,
CAS_190383-13-2,
Ser-Leu-Ile-Gly-Lys-Val-amide, >=95% (HPLC), solid,
L-Valinamide,L-seryl-L-leucyl-L-isoleucylglycyl-L-lysyl-,
CS-7032,
CID10483914,
CID 10483914,
A8677,